Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. (ARMP) Revenue
Annual & quarterly revenue history · segment & region breakdown
ARMP · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsArmata Pharmaceuticals, Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 5.22% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2004 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | -$0.00B | -5.22% |
| 2024-12-31 | $0.01B | +$0.00B | +14.24% |
| 2023-12-31 | $0.00B | -$0.00B | -17.77% |
| 2022-12-31 | $0.01B | +$0.00B | +23.11% |
| 2021-12-31 | $0.00B | +$0.00B | +443.62% |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | +$0.00B | — |
| 2018-12-31 | $0.00B | -$0.00B | -100.00% |
| 2017-12-31 | $0.00B | -$0.00B | -55.77% |
| 2016-12-31 | $0.00B | -$0.00B | -45.26% |
Compare revenue vs peers
BiotechnologyCompare ARMP revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Armata Pharmaceuticals, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Armata Pharmaceuticals, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Armata Pharmaceuticals, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ARMP revenue · 4 questionsARMP's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 5.22% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Armata Pharmaceuticals, Inc. SEC filings · GAAP · Armata Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026